
Reference Capital SA
Description
Reference Capital SA is an independent investment company based in Geneva, Switzerland, operating with a distinctive dual strategy in the private markets. The firm serves as both a fund-of-funds investor, deploying capital into various venture capital, private equity, and private debt funds globally, and as a direct investor in high-growth companies. This hybrid approach allows Reference Capital to diversify its portfolio across different stages and asset classes while maintaining a focused direct investment thesis.
The firm's direct investment arm strategically targets companies within the Digital, Sustainability, and Health sectors, identifying businesses with significant growth potential. Reference Capital seeks to partner with innovative companies that are poised for substantial market impact and expansion. As of December 31, 2023, Reference Capital manages over USD 1.5 billion in assets, underscoring its significant presence and capacity within the private investment landscape.
Since its inception, Reference Capital has built a robust track record, having invested in over 100 funds and more than 50 direct companies. Their direct portfolio often features later-stage, high-growth enterprises that have already demonstrated product-market fit and are scaling rapidly. While specific check sizes for direct investments are not publicly disclosed, their participation in significant growth rounds of companies like Nexthink and MindMaze suggests a focus on meaningful capital deployment.
Given their substantial assets under management and the typical stage of their direct investments, Reference Capital's initial direct checks are generally geared towards growth equity or late-stage venture rounds. They aim to provide substantial capital to support the scaling and strategic initiatives of their portfolio companies, often participating alongside other institutional investors in larger syndicates.
Investor Profile
Reference Capital SA has backed more than 54 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 23 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series C, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Switzerland, Germany.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Typical check size: $5M – $20M.
Stage Focus
- Series A (20%)
- Series C (17%)
- Series Unknown (15%)
- Series B (11%)
- Series D (11%)
- Post Ipo Secondary (6%)
- Secondary Market (6%)
- Series G (4%)
- Post Ipo Equity (4%)
- Convertible Note (4%)
Country Focus
- United States (52%)
- Switzerland (24%)
- Germany (9%)
- United Kingdom (7%)
- Romania (2%)
- Canada (2%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Manufacturing
- Software
- Information Technology
- Hardware
- Pharmaceutical
- Professional Services
- Life Science
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.